Increasing doses of quinidine cause increased slowing of the auricular rate in flutter of circus movement origin, and maximally tolerated doses cause reversion to sinus rhythm. Quinidine lengthens conduction time in the nonfluttering auricle, and the effect increases as the dose is increased. Refractory period is lengthened equally by small and large doses. Experimental results suggest that the effects of quinidine on the auriculoventricular conducting mechanisms are of three types, (1) direct depressant, (2) vagal block, and (3) reflex sympathetic stimulation, and that these effects are manifest to different degrees depending upon dose and the state of innervation to the heart.
Increasing doses of quinidine cause increased slowing of the auricular rate in flutter of circus movement origin, and maximally tolerated doses cause reversion to sinus rhythm. Quinidine lengthens conduction time in the nonfluttering auricle, and the effect increases as the dose is increased. Refractory period is lengthened equally by small and large doses. Experimental results suggest that the effects of quinidine on the auriculoventricular conducting mechanisms are of three types, (1) direct depressant, (2) vagal block, and (3) reflex sympathetic stimulation, and that these effects are manifest to different degrees depending upon dose and the state of innervation to the heart.
DlltING the past 30 years considerable information has been accumulated on the effects of quinidine on the heart. Much of the information was obtained indirectly. Multiple, direct leads from the heart have been used otily by Lewis and his associates in 19211 and by Gilbert and co-workers in 1951.2 Lewis and his associates attributed the action of quinidine in auricular flutter to its effect on refractory period. This explanation has been widely accepted. Gilbert and coworkers, however, reported that lengthened refractory period frequently but not always occurs when quinidine prevents fibrillation. The observations of Gold and colleagues3 also conflict with those of Lewis. They found that quinidine accelerated, rather than slowed, the sinus rate and did not influence or even enhance A-V conduction which Lewis and coworkers had reported as being impaired.
In view of the conflicting data, a systematic re-evaluation of quinidine was undertaken. The actions of quinidine on experimental auricular flutter of circus movement origin were determined and were correlated with its auricular and ventricular effects as influenced by auricular rate under controlled conditions. METHOD
The experiments were conducted in 40 dogs, weighing between 16 and 23 Kg., anesthetized by From the Pharmacology Department, Research Laboratories, The Wm. S. Merrell Company, Cincinnati, Ohio. 864 the intraperitoneal injection of 0.7 cc. per kilogram of Dial with urethane solution (Ciba). Blood pressure was recorded from the carotid artery. Auricular electrograms were recorded and the electrocardiogram was taken from pericardial tissue near the ventricular apex. Injections were made into the external jugular vein. The reported results were obtained in dogs in which the blood pressure was at least 60 mm. Hg and the rectal temperature maintained at 37 C. by external heat. Auricular Flutter. Flutter was induced according to the method of Rosenblueth and Garcia Ramos. 4 Either an area of right auricular wall including some auricular and inferior vena caval tissue or a small area on the body of the right auricle was crushed. Brief, rapid electrical stimulation of the auricle then initiated flutter with a regular rate in the range between 300 and 600 beats per minute. Once induced, the flutter continued at a steady rate for many hours. It was demonstrated in many experiments, using the procedure of Rosenblueth and Garcia Ramos, that the flutter induced was of the circus movement type in which a single impulse circulated continuously around or in the vicinity of the crushed area.
Auricular Functions. The auricle was driven with electric shocks, recording at a distance from the point of stimulation. The driving frequency was increased until the maximal rate at which the auricle followed rhythmic stimuli was established. Maximal rate occurs when the interval between stimuli is just longer than that during which no response can be elicited even with high voltages, and is used as a measure of effective refractory period. Electrical excitability was measured by determining the minimal voltage required for the auricle to follow each stimulus at each of the driving frequencies employed. Speed of the recording paper was increased from 15 to 60 mm. per second so that conduction time could be measured. When effects of nerve stimulation were studied, the nerve was stimulated while driving the auricle at each frequency. In all determinations of auricular function, ventricular rate was recorded simultaneously.
Recording and Stimulation. Changes in electrical activity in the auricle were recorded from pairs of silver electrodes with small interelectrodal distance (2 to 3 mm.) which were clipped lightly to the auricular muscle. Stimulating electrodes were of similar design. All recordings were made by means of a four channel ink-writing oscillograph (Grass) and were made continuously during all experiments. A model 3C Grass stimulator giving square waves was employed. For auricular stimulation the pulse duration was always 1 millisecond, the frequency was varied from 2 to 15 per second, and current strength was varied from 0.5 to 15 volts. The duration of stimulation of the auricle was generally about 20 seconds or until adequate records for analysis could be taken. Maximal nerve stimulation was effected by using the lowest frequency of stimulation which slowed or accelerated the ventricle significantly and a voltage above which no further change could be produced. For the cut central end of the vagus this was stimuli of 0.2 or 0.5 millisecond duration at a frequency of 10 to 30 per second and a voltage of 10 to 20. The sympathetic chain was stimulated by placing the electrodes between the stellate and the ganglion of T-2, after freeing the chains of all connections except the postganglionic cardiac fibers arising from the stellate ganglion, using a pulse duration of 0.01 millisecond, a frequency of 2 or 60 per second, and a voltage of between 20 and 40. the dose is increased from 0.5 to 4 mg. per kilogram in both innervated and denervated hearts. The 
RESULTS
Auricular Flutter. The effects of increasing doses of quinidine on auricular and ventricular rates of innervated hearts are illustrated in figure 1. Maximal auricular slowing occurs within two minutes after injection. With doses of 4 mg. per kilogram, the marked slowing was usually followed by sudden reversion to a sinus rate within five minutes at a time when the auricular rate was already recovering. The ventricular rate in innervated hearts during flutter was either increased or decreased by quinidine. In experiments with innervated hearts, these four doses were given successively with an interval between injections sufficient to allow full recovery of blood pressure and of auricular and ventricular rates. The resulting dose-response curves were like those of figure 2. In three of the experiments the ventricular rate was increased at doses intermediate between the minimally effective and maximally tolerated doses. In the fourth experiment no increase of ventricular rate occurred but the slowing caused by the intermediate doses was less than that caused by the small and large doses.
When both vagal and sympathetic innervations to the heart were sectioned, quinidine always slowed the ventricular rate, and the amount of slowing increased slightly but not significantly as the dose was increased ( fig. 2 ). The frequency of reversion from flutter to sinus rate after the injection of different doses of quinidine is given in table 1. The number of reversions produced by doses less than 4 mg. per kilogram is insignificant in both inner-.vated and denervated hearts. When 4 mg. per kilogram was injected, reversion occurred in all of the five innervated hearts studied. The rate of injection ranged between 0.5 and 2 mg. per kilogram per minute depending upon the dose and blood pressure level. The injection rate was slower with large doses in an effort to maintain a blood pressure above 60 mm. Hg. In these experiments doses of 8 to 16 mg. per kilogram were lethal to three of eight dogs when innervation to the heart was intact, while 4 to 8 mg. per kilogram were lethal for three of five dogs in which the heart had been denervated. B. Effect on auricular excitability in terms of voltage relative to that required at the lowest auricular rate: Auricular rate is indicated as its reciprocal, that is, interval between beats. R-1 and R indicate shortest intervals between effective stimuli before and after quinidine, and are an estimation of effecive refractory periods. t interval between responses is shortened, and voltage required for the auricle to follow repetitive stimuli is increased until an interval is reached at which conducted responses fail to occur. This is a measure of effective refractory period and is indicated in the graph of figure   3B by the arrows R. Doses of 8 mg. per kilogram increased thresholds to electrical stimulation, especially at high auricular rates, and lengthened the effective refractory period by 30 to 40 per cent. Doses of 2 mg. per kilogram caused a similar lengthening of effective refractory period but did not significantly alter auricular excitability.
Ventricular Rate. The effect of quinidine on ventricular rate was investigated in 20 dogs according to the procedure previously de-866 1%NTRew To To scribed by Brown and Achesoni.' The auricle was driven by electric shocks at frequencies varying between 200 and 600 per minute.
The relation between ventricular rate and auricular rate was expressed as the ratio V/A, and plotted against the auricular rate (fig. 4 ). The resulting curves indicate the decreasing ability of the ventricle to follow the auricle as the auricular rate is increased; ventricular-auricular ratio (V A) decreases from 1.0 to 0.5 and below. When both vagal and sympathetic nerve supplies to the heart were eliminated, doses of 4 and 8 mg. per kilogram regularly decreased the ventricular-auricular ratio (fig. 4 ). The same doses of quinidine also impaired the depression of ventricular rate produced by vagal stimulation (fig. 5 ), although the magnitude of effect varied from animal to animal and was greatest at rates of auricular stimulation above 300. Similarly, the enhancement of ventricular-auricular ratios during sympathetic stimulation was also impaired ( fig. 05 ).
DISCUSSION
Soon after Drury and Jliescu6l first demonstrated that quinidine slows the rate of auricular flutter and fibrillation, Lewis and coworkers' investigated the effects of quinidine on refractory period and conduction in the dog's auricle by direct measurement, and postulated that reversion from flutter occurred because of a lengthened refractory period. These authors considered the marked slowing of conduction time, but concluded that circus movement was terminated by quinidine only in those cases in which lengthening of refractory period predominated over slowed conduction. The recent report by Gilbert and associates2 stated that, while lengthening of refractory period was the most marked change coincident with termination of postfaradic fibrillation, it was not necessarily an accompaniment.
The influence of refractory period on the mechanism of reversion in circus movement flutter was studied recently by Brown and associates.' Employing compounds which consistently lengthen refractory period, it was found that (a) compounds with little effect on conduction time are more likely to cause reversions of circus movement flutter, siiice the rapidly moving impulse meets refractory tissue, and (b) compounds which lengthened conduction time cause marked slowing of flutter with little tendency to reversion, since there is an adequate interval for recovery from refractoriness in the circuit. The latter relationship appears to hold true for doses of 0.5 to 2 mg. per kilogram of quinidine. Larger doses cause no greater lengthening of refractory period than small doses, but they do cause significantly greater prolongation of conduction time. This would seem to mean that these doses of quinidine would not cause reversions but would merely slow the flutter. Actually, doses of 4 mg. per kilogram consistently cause reversions. The reversions consistently occurred after the peak of conduction velocity slowing ( fig. 1 ). This suggests that recovery from lengthened refractory period proceeds more slowly than recovery from slowed conduction velocity. At the time of maximal slowing of conduction velocity, the gap between head and tail of the impulse is wide enough for flutter to continue. While the mechanisms underlying conduction time begin to recover, the effective refractory period remains lengthened. The result is a shortening of the gap until it is obliterated and reversion occurs. The present investigation thus suggests that the Lewis hypothesis holds true, and that whether or not reversions occur (in experimental circus movement flutter) depends upon the temporal relation between effects of quinidine on refractory period and on conduction velocity. Following the oral administration or intravenous infusion of quinidine a different relationship could exist. Experiments done in this laboratory indicate that quinidine may also markedly slow auricular flutter induced by aconitine according to the method of Scherf. The degree of auricular slowing in these experiments also parallels the amount of slowing of conduction time; however, the auricular electrogram frequently becomes disorganized and may even briefly increase in rate when small doses are administered. Additional evaluations employing aconitine-induced flutter are required before its action in different auricular arrhythmias can be understood.
The ventricular effects of quinidine are due to varying combinations of direct depressant action and its action on the innervation, both of which in turn are dependent upon the dose. Previously, effects of dosage have received little attention and no differences in the effects of different doses have been reported. Regarding innervation, Megibow and Katz8 reported that during faradically maintained auricular fibrillation quinidine depressed A-V conduction in the denervated heart through a direct action but that enhancement occurred in the innervated heart by reflex vagal action arising from vasodepression.
Large doses of quinidine depress the ability of the ventricle to follow the auricle both in innervated and in denervated hearts. Small doses affect ventricular rate similarly. These results can be explained by a direct depressant action of quinidine on auriculoventricular conduction mechanisms. In innervated hearts, doses intermediate between the minimally effective and the maximally tolerated ones often increase ventricular rate during auricular flutter and also may increase the ventricularauricular (V/A) curves in the nonfluttering heart, while both are depressed in denervated hearts by these doses. In addition, intermediate and large doses partially block the effect of vagal stimulation on ventricular rate. These results indicate that a second action of quinidine is that of vagal block. Further, reflex action via the sympathetics is suggested because the ventricular rate is unaffected in vagotomized hearts by doses which cause depression of the ventricular-auricular (V/A) curve in innervated and in denervated hearts.
Since quinidine partially blocks the ventricular effects of sympathetic stimulation, the data suggest that the depressant action may be functionally antagonized by this reflex action. Stated more simply, small doses are adequate to cause direct depression but not to cause effects on the innervation; intermediate doses produce partial vagal block and probably reflex sympathetic action which are of such degree that the direct depressant effect is often obscured, while the direct depression obtained with large doses of quinidine is greater than effects on the innervation. SUMMARY Auricular Effects. Increasing doses of quinidine cause increased slowing of auricular rate in flutter of circus movement origin. Maximally tolerated doses cause reversion to sinus rhythm. In the nonfluttering auricle quinidine lengthens conduction time and the effect is increased as the dose is increased. Refractory period was lengthened similarly by both large and small doses. The threshold of auricular excitability was raised only by large doses and generally only at high auricular rates.
Ventricular Effects. When both vagal and sympathetic nerve supplies to the heart were sectioned, quinidine always impaired the ability of the ventricle to follow the auricle, and slowed the ventricular rate during auricular flutter. Ventricular rate was unaffected when the sympathetics were intact and the vagi were cut. In hearts with intact innervation large and small doses depressed ventricular rate while the effect of intermediate doses was variable.
